Anika Therapeutics appoints Sheryl Conley to Board of Directors; adds orthopedic industry expertise

Anika Therapeutics, Inc.

Appointed Sheryl Conley as independent director effective Oct 28, 2021; board expands from seven to eight members.
Ms. Conley brings over 35 years of orthopedic experience, including 25 years at Zimmer as Group President and CMO.
She will serve on the Audit Committee and received 8,179 restricted stock units vesting over three years.
Currently President of AcceLINX and board member at Neuronetics (STIM) and Surgalign (SRGA).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sheryl L. Conley

Director

ANIK · Anika Therapeutics, Inc.

Effective: 2021-10-28
Filed: November 1, 2021, 7:59 PM ET

elected Sheryl L. Conley as a member of the Board effective as of October 28, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sheryl L. Conley was elected as Director at Anika Therapeutics, Inc..

Action: elected
Role: Director

Exact text from the filing

elected Sheryl L. Conley as a member of the Board effective as of October 28, 2021.

View on SEC.gov

Anika Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001171843-21-007366

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.